37th week of 2012 patent applcation highlights part 38 |
Patent application number | Title | Published |
20120230852 | IMMERSION PUMP ASSEMBLY - An immersion pump assembly includes an electric drive motor and a control device ( | 2012-09-13 |
20120230853 | Scroll Compressor - In a scroll compressor, it is hard to zone a high pressure chamber and a back pressure chamber which are formed in a back face of an orbiting scroll by a sealing means, increase a feeding amount to the high pressure chamber and the back pressure chamber at a low speed and adjust it at a high speed. A sealing means sealing a high pressure chamber in a center portion of a back face of an orbiting scroll and a back pressure chamber formed by an outer peripheral portion is provided, and a spiral shaped throttle passage is provided between a boss portion in the back face of the orbiting scroll and an outer peripheral surface of an orbiting bearing, thereby constructing an oil feeding route for feeding a lubricating oil to the back pressure chamber from the high pressure chamber. | 2012-09-13 |
20120230854 | Scroll Compressor - A scroll compressor with high efficiency is provided according to the present invention. The scroll compressor compresses a refrigerant by meshing of an orbiting scroll and a fixed scroll, wherein the orbiting scroll includes a back pressure hole which intermittently connects a compression chamber and a back pressure chamber per one orbit of the orbiting scroll, and the back pressure hole communicates with the compression chamber and also with the back pressure chamber and shuts off the communication with the back pressure chamber after the communication with the compression chamber is shut off. | 2012-09-13 |
20120230855 | SCROLL COMPRESSOR - A scroll compressor includes a fixed scroll having a fixed wrap, and an orbiting scroll having an orbiting wrap engaged with the fixed wrap to define a first compression chamber between an inner surface of the fixed wrap and an outer surface of the orbiting wrap, and to define a second compression chamber between an inner surface of the orbiting wrap and an outer surface of the fixed wrap. A rotation shaft is provided with an eccentric portion at one end thereof to drive the orbiting scroll. A protruding portion protrudes inwardly from an inner end of the fixed wrap, and contacts the orbiting wrap. A distance between a center of the eccentric portion and a tangent line at a contact point between the protruding portion and the orbiting wrap at an end of the first compression chamber is smaller than a radius of the eccentric portion. | 2012-09-13 |
20120230856 | HELICAL GEAR PUMP - A helical gear pump includes a second helical gear provided coaxially with a drive helical gear, a third helical gear engaged with the second helical gear and provided on a third shaft different from a shaft of the drive helical gear and a shaft of a driven helical gear, and a bearing for supporting the third shaft and receiving a thrust force. | 2012-09-13 |
20120230857 | WATER INJECTION TYPE SCREW FLUID MACHINE - A screw fluid machine has a first non-contact seal, a second non-contact seal and a lip seal disposed between a rotor chamber and a bearing for a rotor shaft located on the high pressure side, and in this order from the rotor chamber side. It includes a pressurized communicating channel for introducing high-pressure target gas into a pressurized space formed between the first and second non-contact seals, a pressurized pressure detecting device for detecting the pressure of the pressurized space, and an alarm device for generating an alarm when a value detected by the pressurized pressure detecting device falls out of a predefined range of pressurized pressures. The screw fluid machine is capable of detecting or predicting a condition of the shaft sealing device and accurately and reliably reporting the detected condition to an operator. | 2012-09-13 |
20120230858 | SCREW PUMP - A first rotor and a second rotor have helical teeth each including a dedendum portion, an addendum portion, and an addendum tip portion. Profiles of the addendum portions of the first and second rotors are formed by cycloidal curves. Profiles of the dedendum portions of the first and second rotors are formed by trochoidal curves. A pitch circle of the second rotor is larger than that of the first rotor. The number of teeth of the second rotor is larger than that of the first rotor. A width angle of the first rotor is not less than a minimum angle at which the addendum tip portions of the first rotor are in line contact with an outer circle of the first rotor, and not more than an angle at which a discharge volume ratio is approximately equal to that at the minimum angle. | 2012-09-13 |
20120230859 | MARAGING STEEL ARTICLE AND METHOD OF MANUFACTURE - A fully dense, powder-metallurgy produced maraging steel alloy article of prealloyed powder for use as a tool for high temperature applications. The article in the as-produced condition having a hardness less than 40 HRC to provide machinability and thereafter the article upon maraging heat treatment having a hardness greater than 45 HRC. A method for producing this article comprises compacting prealloyed powder to produce a fully dense article having a hardness less than 40 HRC and thereafter maraging heat treating to a hardness greater than 45 HRC. | 2012-09-13 |
20120230860 | PURIFICATION PROCESS - A method for purifying metal M | 2012-09-13 |
20120230861 | SWASH PLATE AND METHOD OF MANUFACTURING THE SAME - A swash plate includes aluminum (Al) as a main component and 35˜45 wt % of zinc (Zn), 1.5˜3.5 wt % of copper (Cu), 6˜10 wt % of silicon (Si), 0.2˜0.5 wt % of magnesium (Mg) and other inevitable impurities. A method of manufacturing the swash plate is also provided. | 2012-09-13 |
20120230862 | ALUMINIUM FOIL ALLOY - An aluminium alloy product having a gauge below 200 μm and a composition, in weight %, of Fe 1.0-1.8, Si 0.3-0.8, Mn up to 0.25, other elements less than or equal to 0.05 each and less than or equal to 0.15 in total, balance aluminium. A process of manufacturing the product includes the steps of continuous casting an aluminium alloy melt of the above composition, cold rolling the cast product without an interanneal step to a gauge below 200 μm and final annealing the cold rolled product. The product may be a deep drawn container. | 2012-09-13 |
20120230863 | Bag Made From Medical-Grade Paper That is Treated for Sterilization, with Sterilization-Process Indicators and Pigmented-Adhesive-Based Safety Features, Which is Easy to Handle and Use - The present invention relates to bags made from medical-grade paper for sterilization, with sterilization-process indicators and pigmented-adhesive-based safety features, which is easy to handle and use and can be used to store materials, more particularly surgical medical material, for sterilization. Such bags are produced using medical-grade paper that is treated on the surface thereof with a microbicide for sterilization, and, owing to the structure and design thereof, allow safe, rapid handling of the sterilized material placed within, since there are visual indicators that guarantee the hermetic closure and sealing thereof. Furthermore, generally, the invention has printed indicators that change colour depending on the sterilization process carried out on the bags and on whether said process was carried out correctly. | 2012-09-13 |
20120230864 | Air Treatment Agent Dispenser with Improved Odour Sensor Functionality - A method of operating a dispensing device for at least one air treatment agent is described, the dispensing device comprising: a housing having one or more walls to define an interior adapted to receive at least one removable container of air treatment agent at least partially therein; and within said housing the device comprises: an airborne agent detector means operable to detect airborne agents in the air, wherein said means are provided with at least one aperture to the exterior of the device to permit, in use, air from outside of the device to enter said airborne agent detector means; receiving means for receiving said at least one container of air treatment agent; emanation means adapted, in use, to emanate the air treatment agent from the device through one or more exit orifices in the housing; control means in communication with the emanation means and in communication with said airborne agent detector means; the airborne agent detector means comprises one or more metal oxide semiconductor/metal oxide odour sensors; characterised in that the method comprises the application of power to the sensor(s) in pulses. | 2012-09-13 |
20120230865 | Method and an installation for sterilizing containers by electron bombardment - A method of sterilizing containers by means of an electron gun, the method comprising the steps of inserting the gun into an opening of the container and of applying electron bombardment, and also the step of orienting the container so that it has its opening directed downwards prior to inserting the gun therein. The invention also provides an installation for implementing the method. | 2012-09-13 |
20120230866 | CONTAINER TREATMENT - A method of decontaminating a freight container comprising the steps of: a) placing a freight container on a support; b) using an enclosure to substantially enclose the container on the support; and c) applying heat so that hot air moves within the enclosure around at least upright ends, sides and a roof of the container to kill or substantially weaken undesired life forms on or immediately adjacent to the exterior of the container. | 2012-09-13 |
20120230867 | SANITIZATION DEVICES AND METHODS OF THEIR USE - The present invention relates to sanitization devices and methods. More particularly, the invention relates to devices and methods that significantly reduce or eliminate germs, bacteria and/or other microorganisms from objects such as bags, purses, footwear or other objects, as well as bare feet, hands, paws, hooves or other anatomical surfaces, which come into contact with them. The device and method uses germicidal radiation which exposes only the areas of the object that come into applied contact with the device. A top platform of the devices may be in a tilted position when not in uses. | 2012-09-13 |
20120230868 | Apparatus And Method For Sterilizing Items - A sterilizing apparatus includes an enclosure defining an interior chamber and a door for accessing the interior chamber. A fluid source communicates with the chamber to supply a working fluid thereto. A heater heats the fluid in the chamber and a pump moves the fluid in the chamber by the heater. A valve communicates with the chamber and with the exterior of the chamber and is configured to vent the fluid in the chamber to the exterior at a pressure of approximately one atmosphere. Such provides superheating and concentrating of the working fluid in the chamber. A method of sterilization includes introducing a working fluid into an interior chamber and circulating the fluid through at least one recirculation loop having a heater for heating the fluid to an operational temperature suitable for killing microorganisms. The method further provides for killing of very high temperature resistant microorganisms. | 2012-09-13 |
20120230869 | HYDROGEN PEROXIDE DISINFECTANT CONTAINING A CYCLIC CARBOXYLIC ACID AND/OR AROMATIC ALCOHOL - An aqueous disinfecting solution, a concentrated version of the solution, and a dry powdered composition which may be dissolved in water to provide the solution. The solution has a pH of from 0.6 to 7 and comprises (a) hydrogen peroxide in a concentration of from 0.01 to 6% w/w; and (b) at least one component chosen from cyclic carboxylic acids and aromatic alcohols, in a concentration of from 0.01 to 10% w/w, all based on the total weight of the solution. The cyclic carboxylic acids are preferably 2-furan carboxylic acid, benzoic acid and salicylic acid and the aromatic alcohol is preferably benzyl alcohol. Furthermore, the solution may contain surfactants, corrosion inhibitors, hydrotropes, cation sequestering agents, hydrogen peroxide stabilizers, solvents, thickeners, skin conditioning agents, antifoams, and pH buffers. | 2012-09-13 |
20120230870 | STERILIZATION APPARATUS AND PROCESS - A sterilizing apparatus and a process for sterilizing an article in the sterilizing apparatus, the apparatus including a sterilization chamber and a sterilant introduction system, wherein the sterilant introduction system separately supplies components (A) and (B) to form a composition comprising the components (A) and (B), the components including (A) an anti-microbial agent comprising peracetic acid; and (B) a reagent mixture comprising a buffer, an anticorrosive agent and a chelator; in which the composition is characterized by the absence of molybdate. In the apparatus and in the process, components (A) and (B) may be introduced separately. | 2012-09-13 |
20120230871 | Microbiocidal Control in Drinking Line Systems - This invention provides a method of controlling microbes in a drinking line system when poultry and/or swine are absent from the area where the drinking line system is located. The method comprises I) contacting the drinking line system and an aqueous microbiocidal solution; and II) flushing said drinking line system with water and/or an aqueous solution comprising one or more scale removers at least once after said contacting with said aqueous microbiocidal solution, wherein said aqueous microbiocidal solution is formed from components comprising water and a concentrated aqueous biocidal solution selected from A) an aqueous biocide solution having an active bromine content of about 50,000 ppm or more, which solution is formed from components comprising water and (i) bromine chloride or bromine chloride and bromine, with or without conjoint use of chlorine, and (ii) overbased alkali metal salt of sulfamic acid and/or sulfamic acid, alkali metal base, and water, wherein the relative proportions of (i) and (ii) are such that the atom ratio of nitrogen to active bromine is greater than 0.93, and wherein the pH of the composition is greater than 7, or B) an aqueous biocide solution formed from components comprising water and (i) at least one bromide source selected from ammonium bromide, hydrogen bromide, at least one alkali metal bromide, at least one alkaline earth metal bromide, and mixtures of any two or more of the foregoing, (ii) a chlorine source, optionally (iii) at least one inorganic base, and optionally (iv) sulfamic acid and/or a metal salt of sulfamic acid, or C) a combination of A) and B). Any degradation of the materials of the drinking line system from contact with said aqueous microbiocidal solution is minimal. | 2012-09-13 |
20120230872 | SYSTEMS AND METHODS FOR OBTAINING IMMUNOGLOBULIN FROM BLOOD - The present disclosure relates generally to systems for obtaining a pharmaceutically acceptable immunoglobulin from blood of a donor comprising a first conduit configured to convey blood from the donor to a substrate, wherein said blood includes at least one first component and at least one second component, said first component of the blood including immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; and a second conduit configured to convey at least a portion of the second component of the blood from the first conduit to the donor. | 2012-09-13 |
20120230873 | SAMPLE DISPENSING APPARATUS AND AUTOMATIC ANALYZER INCLUDING THE SAME - The invention provides a small-sized automatic analyzer being compact, enabling a large number of analysis items to be carried out, and having a high processing speed. The automatic analyzer is particularly suitably applied to a medical analyzer used for qualitative/quantitative analysis of living body samples, such as urine and blood. A plurality of sample dispensing mechanism s capable of being operated independently of each other are provided to suck a sample from any one of a plurality of sample suction positions and to discharge the sucked sample to any one of a plurality of positions on a reaction disk. The automatic analyzer having a high processing capability can be thus realized without increasing the system size. | 2012-09-13 |
20120230874 | TEST SENSOR AND METHOD FOR MANUFACTURING THE SAME - According to one embodiment of the present invention, an optical-based test sensor for use in the determination of an analyte in a liquid sample is disclosed. The test sensor includes a base, a polymer carrier, and a test membrane. The base has a capillary channel formed in a surface of the base that is adapted to move a liquid sample from an inlet to a reaction area formed in the base. The polymer carrier has a lower surface adhered to the surface of the base and is disposed over at least a portion of the capillary channel. The test membrane, which contains a reagent, is adhered to the lower surface of the polymer carrier and extends from the polymer carrier into the reaction area. | 2012-09-13 |
20120230875 | CARBON DIOXIDE SEPARATION AND RECOVERY APPARATUS - After absorbing oxygen together with carbon dioxide in an absorber | 2012-09-13 |
20120230876 | AIR PURIFICATION APPARATUS - A method for purifying polluted air having particle phase pollutants and gaseous phase pollutants is provided. The method comprising: separately purifying and treating particle phase and gaseous phase pollutants present in the air; providing a dust cleaning apparatus, a catalytic filter core and a valve for controlling an airflow path within an air purification apparatus; controlling the airflow path for the air to bypass the catalytic filter core in a way that: if the amount of particle phase pollutants is above a predetermined value, the valve is moved to the open position to enable the air to bypass the catalyst filtering core; if the amount of particle phase pollutants is less than a predetermined value, the valve is moved to the closed position to force the air to pass through the catalyst filtering core. | 2012-09-13 |
20120230877 | PROCESSING APPARATUS FABRICATION - A processing apparatus that is formed from a plurality of metal layers that are stacked and aligned together and then connected together to form one or more portions of the processing apparatus. | 2012-09-13 |
20120230878 | SYSTEMS AND METHODS FOR REDUCING OFF-GASSED OZONE - Systems and methods for producing an ozone destructor are disclosed herein. Generally, these systems and methods include an ozone destructor that has a housing defining an air passage duct. In some cases, this air passage duct includes a first chamber and a second chamber that are arranged so that air is able to flow into the first chamber, through the second chamber, and out of the destructor. In some cases, an air drying mechanism is disposed in the first and/or the second chamber. Additionally, in some cases, the ozone destructor further includes multiple mechanisms that reduce ozone to oxygen. In light of these features, the ozone destructor is capable of incrementally drying and reducing air and ozone, respectively, as they pass through the first chamber and the second chamber. | 2012-09-13 |
20120230879 | Ozone Generator Device - An ozone generator cartridge | 2012-09-13 |
20120230880 | Sterilisation and Decontamination Device - A sterilisation, sanitisation and/or decontamination device 1 comprising at least a humidifier unit, an ozone generator unit 60, at least one discharge outlet 16 and a controller for controlling the humidifier and ozone generator units, the at least one discharge outlet 16 comprising at least two at least partially converging plates 72, 74 between which substances are discharged. | 2012-09-13 |
20120230881 | HONEYCOMB FILTERS FOR REDUCING NOx AND PARTICULATE MATTER IN DIESEL ENGINE EXHAUST - Particulate filters for reducing NO | 2012-09-13 |
20120230882 | SLURRY COLUMN GASOLINE ALKYLATION USING GAS PHASE OLEFIN INJECTION - Alkylation systems and processes are provided herein that include a slurry reactor. The slurry reactor receives a reactor feed slurry including catalyst and liquid isobutane, a olefin feed, and a circulating reactor vapor stream, where the slurry reactor produces a reactor liquid effluent stream, the reactor liquid effluent stream including catalyst, isobutane, and a liquid alkylate product. The catalyst in the reactor feed slurry can be regenerated catalyst from a catalyst regenerator. The catalyst can be regenerated after being removed from the liquid alkylate product and isobutane in the reactor liquid effluent stream. | 2012-09-13 |
20120230883 | QUENCHING APPARATUS FOR A REACTOR - A quenching apparatus for a reactor is disclosed. The quenching apparatus includes a quenching unit ( | 2012-09-13 |
20120230884 | WATER ABSORBING MATERIAL AND MANUFACTURING METHOD THEREFOR - Provided is a water absorbing material having a granular core portion and a coating layer portion coating the granular core portion, which does not produce color before use and with which a test result can be determined only after use. In the water absorbing material, the coating layer portion is composed of 90 wt % to 96 wt % of a substrate and 10 wt % to 4 wt % of an excretion test material, the excretion test material contains a porous adsorbent having an adsorbance of 25 wt % or greater and including micropores, and an excretion test indicator adsorbed on the micropores of the porous adsorbent, and the excretion test indicator is added in an amount in the range of 0.015 wt % to 0.10 wt % relative to the total amount of the coating layer portion. | 2012-09-13 |
20120230885 | BENT MICROSTRUCTURES FOR SAMPLING, TRANSPORTING OR DISPENSING A FLUID MEDIA - A device for sampling, transporting and/or disposal of fluid media in the nl and μl-range comprises a substrate with an open or closed capillary-like groove or channel respectively, the substrate with the open or closed groove or capillary respectively is bent or arcuated at least at one location. The substrate comprises at least one end into which the open or closed capillary-like groove or channel respectively is extended, which end is shaped according to its application or use as e.g. needle-like, straight-lined cut, tip-like, at least most half circle-shape, rounded, etc. | 2012-09-13 |
20120230886 | Microfluidic Cytochemical Staining System - The present invention provides devices and associated methods to facilitate multiplexed staining on a slide. The use of multiplexed staining on a single slide allows for more accurate disease diagnosis while also conserving sample. A PDMS based cytology overlay was created that is capable of coupling on-chip morphological, cytochemical, and immunological staining. Morphological and cytochemical staining of blood smears, along with immunostaining of lymph node imprints, was carried out to demonstrate the application of this microfluidic cytology chip (μCC) device. | 2012-09-13 |
20120230887 | DEVICES AND METHODS FOR INTERFACING MICROFLUIDIC DEVICES WITH MACROFLUIDIC DEVICES - The present disclosure is directed generally to devices and methods with the purpose of interfacing microfluidic devices with macrofluidic devices. Specifically, the present disclosure includes the de- | 2012-09-13 |
20120230888 | TEMPERATURE CONTROL SYSTEM - For heating or cooling a sample contained in a vessel portion through a heat transfer member held in contact with the vessel portion, there is used the vessel portion, which has a part formed of an elastic member, expands and contracts for injection and discharge of the sample, is closed other than a connecting port with a channel connected to the vessel, and expands and contracts for injection and discharge of the sample. The vessel portion expands correspondingly to the injection when the sample is injected through an inflow path serving as the channel into the vessel portion contracting in a non-contacting state with the heat transfer member. A predetermined amount of sample is injected into the vessel portion so as to expand the vessel portion, and the vessel portion comes into contact with the heat transfer member. The vessel portion is heated or cooled through the heat transfer member. | 2012-09-13 |
20120230889 | MICROCHIP - A microchip includes a fluid circuit defined by a space formed in the microchip and migrates a liquid present in the fluid circuit to a desired position in the fluid circuit by applying a centrifugal force, the fluid circuit being made of thermoplastic resin. The thermoplastic resin is a polymer having an alkyl group of more than 3 carbon atoms as side chains. | 2012-09-13 |
20120230890 | Method and Apparatus for Isolating Platelets From Blood - A platelet collection device comprising a centrifugal spin-separator container with a cavity having a longitudinal inner surface. A float in the cavity has a base, a platelet collection surface above the base, an outer surface. The float density is below the density of erythrocytes and above the density of plasma. The platelet collection surface has a position on the float which places it below the level of platelets when the float is suspended in separated blood. During centrifugation, a layer of platelets or buffy coat collects closely adjacent the platelet collection surface. Movement of a float having a density greater than whole blood through the sedimenting erythrocytes releases entrapped platelets, increasing the platelet yield. | 2012-09-13 |
20120230891 | HYDROPHILIC DIAGNOSTIC DEVICES FOR USE IN THE ASSAYING OF BIOLOGICAL FLUIDS - Diagnostic in-vitro devices for use in the assaying of biological fluids are provided which include cover plates or backing strips which exhibit hydrophilic properties to assist in transport of the biological fluid or retention of same within the device. Exemplary diagnostic devices include lateral flow devices, microfluidic devices and microtiter plates. The devices may also be comprised of low fluorescent material in order to facilitate any diagnostic determination by use of fluorescent emissions. Hydrophilic properties may be imparted to the cover plates or backing strips by physical or chemical treatment thereof. The cover plates or backing strips may exhibit heat sealable or pressure sensitive properties. | 2012-09-13 |
20120230892 | CARRIER WITH FLEXIBLE MICROASSAY DEVICE AND METHODS OF USE - The disclosure provides a carrier for flexible microassay devices ( | 2012-09-13 |
20120230893 | APPARATUS FOR SEPARATING PITCH FROM SLURRY HYDROCRACKED VACUUM GAS OIL - An apparatus is disclosed for converting heavy hydrocarbon feed into lighter hydrocarbon products. The heavy hydrocarbon feed is slurried with a particulate solid material to form a heavy hydrocarbon slurry and hydrocracked in a slurry hydrocracking unit to produce vacuum gas oil (VGO) and pitch. A first vacuum column separates VGO from pitch, and a second vacuum column further separates VGO from pitch. As much as 15 wt-% of VGO can be recovered by the second vacuum column and recycled to the slurry hydrocracking unit. A pitch composition is obtained which can be made into particles and transported without stickin together. | 2012-09-13 |
20120230894 | Urea-Resistant Catalytic Units And Methods of Using The Same - According to at least one aspect of the present invention, a urea-resistant catalytic unit is provided. In at least one embodiment, the catalytic unit includes a catalyst having a catalyst surface, and a urea-resistant coating in contact with at least a portion of the catalyst surface, wherein the urea-resistant coating effectively reduces urea-induced deactivation of the catalyst. In at least another embodiment, the urea-resistant coating includes at least one oxide from the group consisting of titanium oxide, tungsten oxide, zirconium oxide, molybdenum oxide, aluminum oxide, silicon dioxide, sulfur oxide, niobium oxide, molybdenum oxide, yttrium oxide, nickel oxide, cobalt oxide, and combinations thereof | 2012-09-13 |
20120230895 | SOUR NATURAL GAS SPARGER - An apparatus and method is provided for treating sour natural gas. The apparatus comprises a sparger for use in a high pressure and associated or non-associated sour natural gas environments. The sparger is used to disperse sour natural gas inside a sweeting tower/sulphide treatment vessel to facilitate an efficient transfer of hydrogen sulphide or carbon dioxide from the sour natural gas to a sweeting chemical inside the sulphide treatment vessel. A portion of the sparger exposed to the sulphide treatment environment is protected with a corrosion resistant layer/coating. The corrosion resistant layer protects the substrate metal of the sparger from corrosive environment of the sour natural gas inside or outside of the sparger. Corrosion resistant layer material may be selected so as to prevent the substrate metal from corrosion and suphide cracking. | 2012-09-13 |
20120230896 | REMOVAL OF CARBON DIOXIDE FROM COMBUSION EXHAUST GASES - The invention relates to an absorbent, comprising an aqueous solution (A) of at least one amino acid salt of the formula (I), wherein R | 2012-09-13 |
20120230897 | METHOD FOR RECOVERING CO2 BY MEANS OF CaO AND THE EXOTHERMIC REDUCTION OF A SOLID - This invention involves a cyclic method for capturing CO | 2012-09-13 |
20120230898 | CONTROL SYSTEM FOR NOX REMOVAL DEVICE, NOX REMOVAL DEVICE PROVIDED WITH THE SAME, BOILER PLANT PROVIDED WITH THE SAME, AND METHOD OF CONTROLLING NOX REMOVAL DEVICE - A control system of a NOx removal device is provided with reagent introducing means for introducing a reagent into a fluid, a temperature measuring device that measures a temperature distribution of the fluid, a reagent-concentration calculating portion that calculates a concentration distribution of the reagent introduced into the fluid with the temperature distribution determined at the temperature measuring device, a reagent-flow-rate determining portion that determines a flow rate of the reagent that the reagent introducing means introduces in accordance with the concentration distribution calculated at the reagent-concentration calculating portion, and a reagent-introducing-means control portion that controls the reagent introducing means so as to introduce the reagent into the fluid at the flow rate determined at the reagent-flow-rate determining portion. | 2012-09-13 |
20120230899 | MIXED METAL OXIDE CATALYST FOR DECOMPOSITION OF NITROGEN OXIDES - The present invention relates to a mixed metal oxide catalyst in which a hydrotalcite precursor containing an alkali metal is impregnated or intercalated with a nonprecious metal, a method of manufacturing the same, and a method of decomposing nitrogen oxide using the mixed metal oxide catalyst. The mixed metal oxide catalyst has excellent catalytic activity because it can decompose NO | 2012-09-13 |
20120230900 | Metal Salt-Containing Composition, Substrate, Manufacturing Method of Substrate - An object of the present invention is to provide a metal salt-containing composition which is applicable to many metal source materials, and can be used for forming a compact and uniform metal oxide film comparable to those formed according to a sputtering method, as well as to provide a substrate having a metal complex film on the surface thereof obtained using the metal salt-containing composition, and a substrate having a metal complex film on the surface thereof obtained by further heating the substrate. Moreover, another object of the present invention is to provide a method for manufacturing a substrate having such a metal complex film on the surface thereof. | 2012-09-13 |
20120230901 | PROCESS FOR PRODUCTION OF SILICON TETRACHLORIDE - An aspect of a process for producing silicon tetrachloride comprises chlorinating a silicon-containing substance, preferably a silicon-containing substance that contains a silicic acid biomass, in the presence of a carbon-containing substance that contains ash produced in an industrial process, preferably ash produced in a power-generating facility in which an organic material is combusted and a combustion energy produced is converted into an electric power. | 2012-09-13 |
20120230902 | Electromagnetic Casting Apparatus for Silicon - This invention aims at providing a silicon electromagnetic casting apparatus for accurate and easy manufacturing of high quality silicon ingots. This apparatus uses a furnace vessel | 2012-09-13 |
20120230903 | METHODS FOR INTRODUCTING A FIRST GAS AND A SECEOND GAS INTO A REACTION CHAMBER - Gas distribution units of fluidized bed reactors are configured to direct thermally decomposable compounds to the center portion of the reactor and away from the reactor wall to prevent deposition of material on the reactor wall and process for producing polycrystalline silicon product in a reactor that reduce the amount of silicon which deposits on the reactor wall. | 2012-09-13 |
20120230904 | PRODUCTION OF HIGH PURITY SILICON FROM AMORPHOUS SILICA - A process to the production of silicon from amorphous silica is disclosed. The amorphous silica is formed from a material rich in silica, especially rice husk ash or silica fume. The process comprises subjecting the amorphous silica to leaching with a lixiviant of aqueous mineral acid, especially hydrochloric acid. Preferably, material rich in silica is roasted at a temperature of not more than 850° C., subjected to leaching and then subjected to a second roasting at a temperature of less than 750° C. The process provides for the production of high purity silicon, especially to the production of solar grade silicon (SoG-Si). | 2012-09-13 |
20120230905 | PROCESS FOR PYROLYSIS OF CARBOHYDRATES - The present invention relates to processes for industrial pyrolysis of a carbohydrate or carbohydrate mixture with addition of amorphous carbon, to a pyrolysis product thus obtainable and to the use thereof, especially as a reducing agent in the production of silicon from silica and carbon at high temperature. | 2012-09-13 |
20120230906 | METHOD OF MAKING FLUOROSULFONYLAMINE - The present invention is directed to methods comprising adding NH | 2012-09-13 |
20120230907 | PROCESS FOR PRODUCING CARBON MATERIAL - A process for producing a carbon material comprising heating a compound represented by the formula (1): wherein R represents a hydrogen atom or a C1-C12 hydrocarbon group which may be substituted with at least one selected from the group consisting of a hydroxyl group, a C1-C6 alkoxy group, a C6-C20 aryloxy group, a sulfonyl group, a nitro group, a C1-C6 thioalkyl group, a cyano group, a carboxyl group, an amino group, a C2-C20 acylamino group and a halogen atom, R′ represents a hydrogen atom or a methyl group, and n represents an integer of 3 to 7, at 800 to 3,000° C. under an inert gas atmosphere. | 2012-09-13 |
20120230908 | SUBSTRATE FOR GROWING CARBON NANOTUBES, MANUFACTURING METHOD THEREOF, AND MANUFACTURING METHOD OF ORIENTED CARBON NANOTUBES - A substrate for growing carbon nanotubes capable of elongating single-walled carbon nanotubes of an average diameter of less than 2 nm is provided. The substrate for growing carbon nanotubes | 2012-09-13 |
20120230909 | Hydrogen Generating Fuel Cell Cartridges - A gas-generating apparatus includes a cartridge including a reservoir having a first reactant and a reaction chamber, and a receiver that can include a flow control device. The receiver is adapted to receive the cartridge and to transport the first reactant to the reaction chamber after connection with the cartridge. The flow control device is adapted to stop the transport of reactant when the pressure in the reaction chamber reaches a predetermined pressure. | 2012-09-13 |
20120230910 | METHOD OF PREPARING ZSM-5 ZEOLITE USING NANOCRYSTALLINE ZSM-5 SEEDS - Disclosed herein is a method of preparing ZSM-5, including: providing a nanocrystalline ZSM-5 seed having a size of 70˜300 nm; adding the nanocrystalline ZSM-5 seed to a stock solution including water glass as a silica source, an alumina source, a neutralizer and water to form a reaction mixture; and maintaining the reaction mixture at 150˜200° C. to crystallize the reaction mixture. The method is advantageous in that ZSM-5 having small and uniform crystal sizes and including no impurities can be synthesized in a short period of time. | 2012-09-13 |
20120230911 | TNF-ALPHA BINDING PROTEINS - TNF-α binding proteins, including chimeric, CDR-grafted, and humanized antibodies that bind TNF-α are provided. Binding proteins have high affinity for TNF-α and neutralize TNF-α activity. A binding protein can be a full-length antibody or a TNF-α-binding portion thereof. Methods of making and methods of using the binding proteins are also described. The TNF-α binding proteins are useful for detecting TNF-α and for inhibiting TNF-α activity, including in a human subject suffering from a disease or disorder in which TNF-α activity is detrimental. | 2012-09-13 |
20120230912 | ANTIBODIES SPECIFIC FOR SOLUBLE AMYLOID BETA PEPTIDE PROTOFIBRILS AND USES THEREOF - The invention pertains to a method of measuring Aβ protofibrils in a sample. The method includes the steps of (a) providing a labeled monoclonal antibody or fragment thereof that binds wildtype Aβ 42/40 protofibril and Aβ42/40 Arc protofibril and has no or little cross-reactivity to Aβ 42/40 monomers with an agent that generates a measurable signal, (b) contacting said labeled antibody or fragment thereof with the fluid or tissue having or suspected of comprising Aβ protofibrils, and (c) measuring the amount of protofibrils bound to the antibody by measuring the signal generated by the agent. | 2012-09-13 |
20120230913 | PROTEIN NANOPARTICLE DISPERSIONS - Provided herein, inter alia, are protein dispersions comprising dense protein nanoclusters and methods of making the. Upon dilution, the clusters may reversibly dissociate into native protein molecules with high biological activity. The viscosities of the nanocluster dispersions may be sufficiently low to allow small-volume subcutaneous injections. | 2012-09-13 |
20120230914 | LABELING COMPOUND FOR PET - A labeling compound of the present invention includes a structure represented by formula (1) | 2012-09-13 |
20120230915 | COMPOSITION AND METHOD FOR MEDICAL IMAGING OF BODY CAVITIES - A foamed aqueous image enhancing composition containing cellulose and/or cellulose derivative(s), has a pH between 5.5 and 7, wherein the viscosity of the composition is less than 1800 mPa·sec, and wherein a gas is maintained in the composition for at least 1 minute after preparation. The combination of low viscosity and foam stability makes the composition particularly suitable in patency tests and fallopian tube sterilization checks. | 2012-09-13 |
20120230917 | COMPOSITIONS THAT INCLUDE A HYDROPHOBIC COMPOUND AND A POLYAMINO ACID CONJUGATE - Various compositions that include a hydrophobic compound and a polyamino acid conjugate are prepared. The compositions described herein are useful for a variety of drug, biomolecule, and imaging agent delivery applications. | 2012-09-13 |
20120230918 | NON-INVASIVE IN VIVO OPTICAL IMAGING METHOD - The present invention relates to a non-invasive method of determining the presence, quantifying the blood level, and/or monitoring or determining the blood clearance of a fluorescent analyte which comprises a fluorescent entity and a second entity, in the blood of a subject, comprising or consisting of the steps: (a) directing excitation light of at least one predetermined wavelength onto a delineated region comprising at least a portion of the pupil of said subject, to excite the fluorescent entity, (b) receiving light emitted from said fluorescent analyte with a wavelength distinguishable from the predetermined wavelength of (a), through the eye of said subject, thereby determining the presence, quantifying the blood level, and/or monitoring or determining the blood clearance of said fluorescent analyte in the blood of said subject. The present invention further relates to a fluorescent analyte or fluorescent label as defined in any one of the preceding claims for use in any one of the preceding methods. The present invention furthermore relates to the use of a fluorescent analyte or fluorescent label as defined in any one of the preceding claims for the preparation of a diagnostic composition which is to be employed in any one of the preceding methods. The present invention furthermore relates to a device for use in any of the methods defined herein. | 2012-09-13 |
20120230919 | MRI CONTRAST AGENT COATED WITH CARBOXYLATED MANNAN AND METHOD FOR PRODUCING THE SAME - The present invention relates to a magnetic resonance imaging (MRI) contrast agent coated with carboxylated mannan, particularly a carboxylated mannan coated superparamagnetic MRI contrast agent specifically targeting antigen presenting cells and having excellent in vivo stability, and a method for producing the same. The MRI contrast agent coated with carboxylated mannan of the present invention can provide excellent in vivo stability and biocompatibility owing to its high surface negative charge, and can be introduced specifically into antigen presenting cells owing to mannose of mannan, so as to visualize the antigen presenting cells and the tissue containing the antigen presenting cells in MRI. | 2012-09-13 |
20120230920 | COSMETIC FORMULATION CONTAINING A NON WATER-SOLUBLE AMPHIPHILIC COPOLYMER AS THICKENING AGENT - The present invention concerns formulations containing one or more comb structure amphiphilic copolymers that are both rich in hydrophobic monomers and in polyalkylene glycol monomers. Cosmetic formulations. Methods of thickening. | 2012-09-13 |
20120230921 | NITRIC OXIDE RELEASING PARTICLES FOR ORAL CARE APPLICATIONS - The present invention provides an oral care composition comprising a nitric oxide releasing particle and an orally-acceptable carrier. The nitric oxide releasing particle comprises at least one nitric oxide donor. Another aspect of the present invention provides a device for oral care comprising a nitric oxide releasing particle, wherein the device is configured to expose a targeted site in an oral cavity of a subject to nitric oxide. The present invention also provides methods and uses of providing oral health benefits by using the oral care compositions or devices as described above. | 2012-09-13 |
20120230922 | Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same - Embodiments of this invention encompass a method for producing and purifying rebaudioside C. In particular, this invention relates to a method for purifying rebaudioside C compositions to obtain a substantially pure rebaudioside C product using one or more crystallization steps. Resulting polymorphic forms of rebaudioside C, substantially pure rebaudioside C compositions and their uses are disclosed. | 2012-09-13 |
20120230923 | Health-Beneficial Preparation and Production Method - The invention relates to the field of health-promoting compositions and to their preparation method. | 2012-09-13 |
20120230924 | Indoline Derivatives And Their Use As Flavouring Agents - Organic compounds of formula (I) | 2012-09-13 |
20120230925 | STABILIZATION OF HOUSEHOLD, BODY-CARE AND FOOD PRODUCTS BY USING BENZOTROPOLONE CONTAINING PLANT EXTRACTS AND/OR RELATED BENZOTROPOLONE DERIVATIVES - Disclosed is the use of benzotropolone derivatives of formula (1), wherein R | 2012-09-13 |
20120230926 | Method For Cosmetically Treating Caspase-14 Deficiency - A method of cosmetic care comprising activating capsase-14 expression in skin deficient in caspase-14 expression by applying, on at least one skin zone in need thereof, an effective amount of a plant extract selected from the group consisting of | 2012-09-13 |
20120230927 | CYCLOMETHICONE-FREE COSMETIC AND PERSONAL CARE PRODUCTS - A personal care or cosmetic composition that includes from about 0.1% to about 99% of at least one ester of alkoxylated aromatic alcohol and fatty carboxylic acid, and from about 0.1% to 60% of at least one functional ingredient is provided. The functional ingredients in the composition may include active ingredients and additional ingredients. Especially suitable active ingredients are sunscreen active ingredients and antiperspirant active ingredients. These compositions include a reduced amount of a cyclomethicone and preferably one substantially cyclomethicone-free. | 2012-09-13 |
20120230928 | COMPOSITIONS OF ACTIVE INGREDIENTS - The present invention relates to compositions containing fat-soluble active ingredients and/or colorants in a matrix based on improved modified polysaccharides, i.e. modified polysaccharides where parts were separated, and to a process for preparing these compositions as well as to these improved modified polysaccharides themselves and a process for the manufacture thereof. | 2012-09-13 |
20120230929 | Composition of a water-soluble sunscreen preparation for acne rosacea - A topical skin care dihydroxyacetone-free final gel formulation to protect skin from ultraviolet rays comprising dispersed: titanium dioxide; 5-hydroxy-tryptophan; histidine; and N-acetyl-tyrosine. | 2012-09-13 |
20120230930 | Methods For Activating Caspase-14 Expression In Human Skin - A method for treating human skin comprising the steps of a) identifying a subject deficient in caspase-14; wherein the caspase-14 deficiency is identified by the presence of a skin condition selected from the group consisting of eczema, xerotic skin, and skin dryness in at least one skin zone of the subject; and b) activating caspase-14 in human skin by administering to a subject in need thereof a therapeutically effective amount of a composition comprising one or more extracts selected from the group consisting of litchi, glasswort, peach, soja seed, sweet basil, cucumber, chanterelle, leek, kiwi fruit, rhubarb, grapefruit, wheat, raspberry, plum, and mixtures thereof. | 2012-09-13 |
20120230931 | Sun-Care Compositions - A sun-care composition having an SPF value of at least 15 comprising: (a) one or more sun care actives including a ów-resorcinyl triazine compound; (b) an aery late s/octyl acrylamide copolymer; and (c) a pharmaceutically/cosmetically/dermatologically acceptable vehicle. | 2012-09-13 |
20120230932 | SILYL POLYMERIC BENZOIC ACID ESTER COMPOUONDS, USES, AND COMPOSITIONS THEREOF - The present invention relates to organosilicon polymers containing benzoic acid esters in form of particles, process for their preparation, cosmetic or dermatological composition comprising them, as well as their use for protecting a human or animal living body from UV radiation. | 2012-09-13 |
20120230933 | STICK-TYPE COSMETIC AND METHOD OF MANUFACTURING THE SAME - A stick-type cosmetic includes a solid wax whose content is more than or equal to 5% by weight and less than or equal to 8% by weight, wherein hardness of the stick-type cosmetic is more than or equal to 0.1 and less than or equal to 0.4, and gloss of the stick-type cosmetic is more than or equal to 30. | 2012-09-13 |
20120230934 | HAIR COSMETIC - The present invention relates to a hair cosmetic composition including a surfactant and a cationized hydroxypropyl cellulose, wherein the cationized hydroxypropyl cellulose contains a main chain derived from an anhydroglucose represented by the following general formula (1) and has a cationized ethyleneoxy group substitution degree of from 0.01 to 2.5 and a propyleneoxy group substitution degree of from 0.1 to 2.8, | 2012-09-13 |
20120230935 | SOLVENT COMPOSITION FOR ONE-STEP PERMANENT WAVE AND HAIR STRAIGHTENER - Disclosed herein is a solvent composition for one-step permanent wave and hair straightener, comprising: amino acid or a derivative thereof; protein or a derivative thereof; a reducing agent; an alkaline agent; an amino acid-based surfactant; organic acid; alcohol; and urea. The solvent composition does not damage hair nor irritate the scalp, does not emit an odor, and can greatly improve the efficiency of curling and straightening hair and the ability to maintain the curled and straightened hair. | 2012-09-13 |
20120230936 | GEL AIR FRESHENER WITH IMPROVED LENGTH-OF-LIFE AND METHOD FOR PRODUCING SAME - The present invention is a solid and self-standing carrageenan gel air freshener composition that exhibits slowed evaporation and extended length-of-life made possible by the addition of relatively small amounts of extenders consisting of C | 2012-09-13 |
20120230937 | IMPLANTABLE BIO-RESORBABLE POLYMER - The present invention relates to a polymer obtained from the polymerization of: (i) at least one monomer of formula (I) (CH | 2012-09-13 |
20120230938 | Polyconjugates for In Vivo Delivery of Polynucleotides - The present invention is directed to compounds, compositions, and methods useful for delivering polynucleotides or other cell-impermeable molecules to mammalian cells. Described are polyconjugates systems that incorporate targeting, anti-opsonization, anti-aggregation, and transfection activities into small biocompatible in vivo delivery vehicles. The use of multiple reversible or labile linkages connecting component parts provides for physiologically responsive activity modulation. | 2012-09-13 |
20120230939 | METHODS FOR TREATING CANCER USING PROSTATE SPECIFIC ANTIGEN AND TUMOR ENDOTHELIAL MARKER PEPTIDES - The present invention is directed to prostate specific antigen (PSA) and tumor endothelial marker 8 (TEM8) peptide compositions and methods for treating cancer with the compositions. | 2012-09-13 |
20120230940 | CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE - Novel products comprising conditioned cell culture medium compositions and methods of use are described. The conditioned cell medium compositions of the invention may be comprised of any known defined or undefined medium and may be conditioned using any eukaryotic cell type. Once the cell medium of the invention is conditioned, it may be used in any state. Physical embodiments of the conditioned medium include, but are not limited to, liquid or solid, frozen, lyophilized or dried into a powder. Additionally, the medium is formulated with a pharmaceutically acceptable carrier as a vehicle for internal administration, applied directly to a food item or product, or formulated with a salve or ointment for topical applications. Also, the medium may be further processed to concentrate or reduce one or more factors or components contained within the medium. | 2012-09-13 |
20120230941 | Methods for treating nervous system injury and disease - The invention is directed to methods for treating nervous system injury and disease, in particular traumatic brain injury and degenerative nervous system disease. Such methods utilize novel compositions, including but not limited to trophic factor-secreting extraembryonic cells (herein referred to as TSE cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells) and conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), each alone or in combination with each other and/or other agents. | 2012-09-13 |
20120230942 | GEP, a novel chondrogenic growth factor and target in cartilage disorders - The present invention relates to the expression and regulating growth factors in chrondrocytes and developing cartilage, particularly granulin-epithelin precursor (GEP). The invention relates to the modulation and manipulation of these growth factors, GEP, and/or the molecules they interact with, for instance COMP, in cartilage disorders, including arthritis. Assays and screening methods for the determination of the expression and activity of GEP, or of GEP-COMP, are provided, including for screening for the presence or extent of cartilage or arthritic disease and for identifying modulators or compounds/agents for treatment or prevention of cartilage or arthritic diseases. | 2012-09-13 |
20120230943 | MODULATION OF ADIPOSE TRIGLYCERIDE LIPASE FOR PREVENTION AND TREATMENT OF CACHEXIA, LOSS OF WEIGHT AND MUSCLE ATROPHY AND METHODS OF SCREENING THEREFOR - The present invention relates to agents, and methods for identifying compounds, which agents and compounds are effective in the treatment, and more particularly, that inhibit cachexia, and its associated or related disorders and conditions. In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by cachexia, and its associated or related disorders and conditions and/or cachexia, and its associated or related disorders and conditions, such as for example, cancer cachexia and cachexia associated with AIDS, autoimmune disorders, drug addiction, alcoholism, chronic inflammatory disorders, cirrhosis of the liver, anorexia and neurodegenerative disease. In particular, the diagnostic marker and drug target of the invention is the ATGL Lipase, which can be inhibited by e.g. siRNAs and compounds with any of the following structures (I). | 2012-09-13 |
20120230944 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS - The present invention relates to compositions and methods for the preparation, stabilization, and/or storage of active agents, particularly therapeutic proteins and polypeptides such as Interleukin-2. | 2012-09-13 |
20120230945 | TARGETED PARTICLES AND METHODS OF USING THE SAME - Drug delivery compositions and methods of delivering compounds are disclosed. Vaccines and methods of immunizing individuals are disclosed. Compositions for drug delivery including gene therapy and methods of treating individuals using such compositions are disclosed. | 2012-09-13 |
20120230946 | FUSION MOLECULES AND IL-15 VARIANTS - The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the such proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention. | 2012-09-13 |
20120230947 | BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY - The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications. | 2012-09-13 |
20120230948 | BRACHYURY POLYPEPTIDES AND METHODS FOR USE - It is disclosed herein that Brachyury is expressed in human tumors, specifically in tumors of the small intestine, stomach, kidney, bladder, uterus, ovary, and testes, as well as in lung, colon and prostate carcinomas. Immunogenic Brachyury polypeptides are disclosed herein. These polypeptides can be used in diagnostic assays for Brachyury expression, as well as for inducing an immune response to Brachyury. Polynucleotides encoding the immunogenic Brachyury polypeptides, vectors including these polypeptides, host cells transformed with these vectors, and methods of using these polypeptides, polynucleotides, vectors, and host cells are provided. Methods of diagnosing a Brachyury-expressing cancer are also provided. Exemplary cancers include small lung, colon, intestine, stomach, kidney, bladder, uterus, ovary, and testes and prostate cancers. Methods of treating cancer are also disclosed. | 2012-09-13 |
20120230949 | CRYSTALLINE FORMS OF N-(TERT-BUTOXYCARBONYL)-3-METHYL-L-VALYL-(4R)-4-((7-CHLORO-4-METHOXY-1-IS- OQUINOLINYL)OXY)-N-((1R,2S)-1-((CYCLOPROPYLSULFONYL)CARBAMOYL)-2-VINYLCYCL- OPROPYL)-L-PROLINAMIDE - The present disclosure generally relates to crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide. The present disclosure also generally relates to a pharmaceutical composition comprising one or more of the crystalline forms, as well of methods of using the crystalline forms in the treatment of Hepatitis C virus (HCV) and methods for obtaining such crystalline forms. | 2012-09-13 |
20120230950 | Compositions and Methods for Soft Tissue Augmentation - The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation. | 2012-09-13 |
20120230951 | ANTIVIRAL COMPOUNDS - The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection. | 2012-09-13 |
20120230952 | DETECTION OF BLADDER CANCER - Provided are methods for detecting bladder cancer in a subject. In some aspects, methylation of one or more of MYO3A, CA10, NKX6-2, SOX11, DBC1, NPTX2, and/or A2BP1 in DNA sediment from a urine sample may be evaluated to detect the presence or absence of a bladder cancer in a human patient. | 2012-09-13 |